Salarius Pharmaceuticals Inc - Bathi mangsa ngarep SLRX

SLRX (Salarius Pharmaceuticals Inc) - tandha merek perusahaan

Salarius Pharmaceuticals (SLRX) is developing targeted oncology therapies that remain independent of economic cycles. The absence of commercial products makes the business dependent on venture capital investments. The future profit model visualizes these aspects, where the indicator is maintained at . Growth prospects are determined by the success of seclidemstat trials and new partnerships in the field of epigenetics.

SLRX: Bathi mangsa ngarep salariuspharma.com 04.07.2022 - 18.11.2026

Salarius - rincian analitis lan metrik utama (SLRX)

Analisis fundamental perusahaan:SLRX, Salarius Pharmaceuticals Inc
Barang utama Salarius Pharmaceuticals Inc

For Salarius Pharmaceuticals (SLRX), the earnings forecast serves as a key indicator for assessing the monetization potential of rare oncology drugs. This metric synthesizes market expectations and current cash flows, offsetting the delays inherent in standard financial reporting. By analyzing the organization's future earnings trend, an investor can track the valuation dynamics of future patents. The pricing power of innovative inhibitors directly determines the upward trajectory of this indicator. This metric confirms the business's operational resilience prior to the market launch of the drugs.

Analisis pesaing

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep RVMD (RevMed)|AAPG (Ascentage) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CGON (cgoncology.com)|URGN - Bathi mangsa ngarep|BCAX: Bathi mangsa ngarep|PSNL - Proyeksi bathi mangsa ngarep|Erasca Corp (ERAS) - Bathi sing dikarepake|Delcath - Penghasilan resik sing dikarepake|YMAB (Y-mAbs Therapeutics Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Aura Biosciences, Inc. AURA|Proyeksi bathi mangsa ngarep CADL|Proyeksi bathi mangsa ngarep Accuray (ARAY)|Bathi sing dikarepake SELLAS Life Sciences Group Inc. SLS|ACTU - Bathi mangsa ngarep|CTOR: Bathi mangsa ngarep|Penghasilan resik sing dikarepake HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Bathi mangsa ngarep|Bathi resik sing dikarepake Fate Therapeutics Corp (FATE)|Bathi mangsa ngarep WHWK|Prakiraan bathi resik TCRX (TScan Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep CSBR|XBIT - Bathi resik sing dikarepake|CEL-SCI Corporation - Bathi mangsa ngarep|Penghasilan resik sing dikarepake OSTX|radiopharmtheranostics.com - Proyeksi bathi mangsa ngarep|ARTV: Bathi sing dikarepake|ANL (adlainortye.com) - Bathi mangsa ngarep|VERU - Prakiraan bathi perusahaan|TPST (Tempest Therapeutics, Inc.) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep xiliotx.com|Bathi sing dikarepake Enochian BioSciences (RENB)|Bathi sing dikarepake MURA (Mural Oncology PLC)|Bathi sing dikarepake Kairos Pharma Ltd KAPA|Proyeksi bathi mangsa ngarep OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan Curis CRIS|APLM: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Tharimmune, Inc.|ADVB (Advanced Biomed) - Proyeksi bathi mangsa ngarep|Genprex - Bathi forward|Bathi sing dikarepake calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XBIO (Xenetic Biosciences)|Purple Biotech - Bathi sing dikarepake|AONC: Bathi mangsa ngarep|BGNE - Proyeksi bathi mangsa ngarep|CKPT (checkpointtx.com) - Bathi mangsa ngarep|Bathi resik sing dikarepake elevationoncology.com (ELEV)|Bathi mangsa ngarep ICAD|ikenaoncology.com (IKNA) - Prakiraan bathi perusahaan|Bathi sing dikarepake Notable Labs, Ltd. (NTBL)|Bathi sing dikarepake VIRX (Viracta Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake